home

New Digital Company Attacks Hard-To-Kill Cancer With Software

Frontiergereports2016-04-19 09:55 Read   77

No one illustrates the promise of cell therapy better than a little girl named Emily Whitehead. She was just 5 years old when she got sick with a common type of childhood cancer called acute lymphoblastic leukemia. Roughly 98 percent of children go into remission within weeks of treatment, but Emily relapsed repeatedly despite several rounds of chemotherapy.

AACR – Mage-A3 double-whammy hits Kite

Frontierepvantage2016-04-18 14:14 Read   64

Given its relevance to Kite Pharma, the NCI’s data on an engineered T-cell receptor against Mage-A3 was a keenly awaited AACR presentation, but when it went live on Sunday researchers could boast of no new responses versus what had been presented last November.

Phibro Animal Health Corporation Reiterates Safety of Mecadox®

FrontierGLOBE NEWSWIRE2016-04-18 13:20 Read   68

Today, the Food and Drug Administration (FDA) issued a press release stating its intention to take the initial steps in the process to rescind its approval of Mecadox® (carbadox)

Sunscreen Delays Melanoma in Mice, Researchers Say

FrontierDRUGS2016-04-18 10:28 Read   60

Applying 30 SPF sunscreen to mice before they were exposed to ultraviolet-B (UVB) radiation delayed the development of melanoma, researchers report.

GlaxoSmithKline Selects TierPoint to Support Global Data Consolidation and Recovery Operations

Frontiermarketwired2016-04-18 10:18 Read   92

TierPoint, a leading national provider of hybrid IT solutions, announced that it has been selected by GlaxoSmithKline (GSK) to support the company's global data consolidation and protection initiatives.

Carbylan Therapeutics Announces Decision to Pursue Strategic Transaction

Frontierglobenewswire2016-04-18 10:05 Read   60

Carbylan Therapeutics (NASDAQ:CBYL), a specialty pharmaceutical company, announced today that it has suspended further clinical development of Hydros-TA and that it is actively pursuing a strategic transaction, including a merger or acquisition of the company.

Ex-BGI CEO’s startup hits $1B valuation in 6 months

Frontierfiercebiotech2016-04-18 09:48 Read   74

Jun Wang has moved quickly since stepping down as CEO of Chinese genomics giant BGI to set up an artificial intelligence-enabled health data mining venture, iCarbonX.

Euronext Welcomes Swiss Biotechnology Pioneer GeNeuro To Paris Market - Raises €33 Million, Market Capitalisation Totals €190

Frontiermondovisione2016-04-18 09:36 Read   56

Euronext today celebrated the listing of GeNeuro, a biopharmaceutical company developing new treatments for autoimmune diseases including multiple sclerosis, in Compartment B of its regulated market in Paris.

DAA therapy for HCV aids in deactivation, delisting of transplant patients

Frontierhealio2016-04-15 17:32 Read   56

Nearly 20% of patients with hepatitis C virus who received direct-acting antiviral therapy while on a transplant waiting list improved enough to be delisted, according to data presented here.

Cydan, NEA’s Orphan Drug Accelerator, Targets Sickle Cell With Startup Imara

Frontierxconomy2016-04-15 17:04 Read   63

Cydan Development, New Enterprise Associates’s orphan drug startup accelerator, has taken a look at around 600 assets since it was formed some three years ago. Sifting through all these potential drugs for diamonds in the rough has been an exhaustive process, perhaps even more so than the firm’s executives expected.

Tobira Therapeutics and Dong-A ST Enter Into License Agreements for Evogliptin and Cenicriviroc

Frontierprnewswire2016-04-15 13:23 Read   97

Tobira Therapeutics, Inc. and Dong-A ST Co., Ltd., today announced that the companies have entered into two separate licensing agreements.

Touts thwart top-level reforms at China's public hospitals

Frontierfiercepharma2016-04-15 11:02 Read   90

China's repeated efforts to reform the public hospital system by getting patients to smaller clinics first and curbing graft in a system under intense demand and supply strains has met its match in swarms of touts who promise quick appointments in exchange for cash.